The stock market experienced some wild swings and increased volatility on Monday. The Dow finished the day up 27 points while the Nasdaq fell 5 points. The crew at CNBC's "Fast Money" brought in technical analyst Andrew Burkly to discuss patterns in the market. Plus, interviews with corporate leaders of Garmin and DaVita.

Image placeholder title

Karen Finerman was relieved that the stock market didn't fall off a cliff on Monday. Guy Adami explained that Goldman Sachs was out talking up a recession and that had a lot of investors scared. Jeff Macke wasn't impressed that the market hit the 10% correction point and could barely put together anything meaningful on the upside. He feels this market continues to be sick.

Reading the Charts with Andrew Burkly

Brown Brothers Harriman technical strategist Andrew Burkly joined the "Fast Money' crew to discuss his take on the markets. Burkly mentioned that he is bullish on the stock market for the second half of the year. However, he thinks the S&P 500 will break below 1370, which is a technically significant area of support. He also mentioned it's too early to buy the financials after the

Financial Select Sector SPDR

(XLF) - Get Report

broke $28. He would wait till the XLF builds a base before looking to buy the financials. Burkly likes the uptrending chart on the

Energy Select Sector SPDR

(XLE) - Get Report

and he thinks it's a buy in the mid-$70's. Najarian cautions investors to stay away from the financials.

(Here's a portfolio based on technician Dorsey Wright's strategy on Stockpickr.com

DWA Technical Leaders

.)

Garmin CFO Interview

Shares of GPS maker

Garmin

(GRMN) - Get Report

have been under tremendous selling pressure over the past month. Can a new line of products set to be released this week at CES, return the stock back to an uptrend? Garmin Chief Financial Officer Kevin Rauckman joined the "Fast Money" crew to discuss Garmin's prospects. Rauckman explained that Garmin is set to introduce 7 new products that are either next generation or brand new products at CES. He went on to say that GPS products have hit the mass market and with that comes lower prices. Rauckman feels the way to stay ahead of lower prices is to come out with new technologies like their speech recognition products. None of the traders want to touch this stock right now.

DaVita CEO Interview

DaVita

(DVA) - Get Report

Chief Executive Kent Thiry joined the "Fast Money" crew to discuss his take on DaVita's prospects. Thiry explained that DaVita is under a lot of scrutiny about their drugs right now, but he is confident the company will thrive despite the scrutiny. He explained the scrutiny isn't hurting their business at all, because decisions on how their drugs are used are made by physicians.

Health Care Conference Update

Healthcare stocks put in a strong day Monday as the JPMorgan Health Care Conference kicked off. Najarian believes that

Pfizer

(PFE) - Get Report

is a name that a lot of investors are looking at right now because the stock is trading at a P/E of 10. He also mentioned that a lot of people are excited about

Merck

(MRK) - Get Report

and

Eli Lilly

(LLY) - Get Report

.

Isis Pharmaceuticals

(ISIS)

soared 47% after the biopharmaceutical company announced a strategic licensing deal for a Lipid-lowering treatment with

Genzyme

(GENZ)

. Najarian remarked that this could be an annual $2 billion drug for ISIS, however he cautioned investors to sell some if they owned it.

(Check out this portfolio of healthcare stocks on Stockpickr.com

Top Yielding Healthcare Stock

.)

Tech Dump

The NASDAQ fell for the seventh day in a row Monday. Shares of

Apple

(AAPL) - Get Report

,

Google

(GOOG) - Get Report

,

Hewlett-Packard

(HPQ) - Get Report

and

Research In Motion

(RIMM)

all took a hit as investors continued to dump tech shares. Adami , though, continues to like

Microsoft

(MSFT) - Get Report

. Macke disclosed he is still long half of his position in

Intel

(INTC) - Get Report

but he isn't buying more because the stock behaves horribly. Najarian suggests Apple is a buy on Friday going into Macworld on Monday.

A Cup of Joe

McDonald's

(MCD) - Get Report

announced plans to install coffee bars at its 14,000 U.S. locations starting this year. While

Starbucks

(SBUX) - Get Report

traded up 4.5% after hours Monday when former CEO Howard Schultz said he will return as CEO to help the coffee chain focus on international growth. Macke made a sea change on Starbucks and he is now bullish on the stock for the next six months.

Blood Trade

A string of Wall Street firms are now coming out and warning investors that a recession and correction for the stock market might be in the cards. Morgan Stanley issued its 2008 outlook report titled "There Will Be Blood" which highlighted stocks to own or sell in the event of a recession. Morgan Stanley suggests investors should short

Best Buy

(BBY) - Get Report

,

Caterpillar

(CAT) - Get Report

, consumer electronics and cyclical building materials and be long

Phillip Morris

(MO) - Get Report

and

Coke

(KO) - Get Report

.

Finerman loves Phillip Morris and she agrees with Morgan. Adami also likes Phillip Morris, but he wouldn't short Caterpillar. Macke explained he wouldn't short Best Buy, instead he would just walk away from the stock. He also favors Phillip Morris. Najarian recommends owning Cokes, smokes, drugs and

McDonald's

.

Earnings Trade

Alcoa

(AA) - Get Report

is set to start the earnings season on Wednesday after the close. Dylan Ratigan highlighted three things that investors should look for this earnings season: Watch for health care to live up to its defensive role, more writedowns, but they are priced in and words will matter more than numbers.

Najarian mentioned he likes

Pfizer

(PFE) - Get Report

,

Lilly

(LLY) - Get Report

and

Biogen

(BIIB) - Get Report

. Adami thinks that financials like

Goldman Sachs Group

(GS) - Get Report

and

U.S. Bancorp

(USB) - Get Report

should be rewarded for not having to do any writedowns. Finerman predicts we will see more writedowns from

Citigroup

(C) - Get Report

and

Merrill Lynch

(MER)

.

Pops & Drops

Pops -

Sallie Mae

(SLM) - Get Report

traded up 7% after the student loan lender hired a new chairman and CFO. Finerman advises getting out of SLM.

ICICI Bank

(IBN) - Get Report

traded up 10% after the Mumbai-based bank said they might IPO out their mortgage business. Najarian likes IBN.

Home Depot

(HD) - Get Report

traded up 2% on no news. Macke sees no reason to bother with HD.

Krispy Kreme

(KKD)

traded up 11% after the donut maker's CEO Daryl Brewster resigned and will be replaced by Chairman James Morgan. Macke commented that the stock will never look good to him.

Drops -

Hewlett-Packard

(HPQ) - Get Report

fell 3%. Adami maintains that HPQ is attractive.

Crocs

(CROX) - Get Report

fell 14% on reports of slowing business. In Finerman's opinion, the selloff is overdone.

Goldman Sachs Group

(GS) - Get Report

fell 3% on no news. Adami still thinks that GS is a buy.

NetSuite

(N)

fell 12%. Najarian disclosed that he bought some NetSuite on Monday.

Solarfun

(SOLF)

fell 16% as oil sold off Monday. Finerman warns investor to stay away.

Final Trade

The team passes along trades that they think will be profitable.

Stockpickr is a wholly owned subsidiary of TheStreet.com.